Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/18/19
End: 10/26/23
Due: 10/26/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer | NCT03958721 | A Bapsi Chakravarthy, MD | user2@example.com | None | 2019-07-18 | 2023-10-26 | 2024-10-26 | - | - | 2025-07-14 |